- Global Pharma News & Resources

New Research Report on Viscosupplementation Market by Forecast to 2021 to 2027 with Covid-19 Impact Analysis and Future Business Opportunities

Coherent Market Insights released a new market study on 2021-2027 Viscosupplementation Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Viscosupplementation Market Forecast till 2027*.

Request Here For Market Latest Insights:

Viscosupplementation is a minimally invasive procedure that helps reduce joint pain and improves the functional condition of the osteoarthritic joint. It is a treatment in which a thick fluid named hyaluronate or hyaluronic acid is injected into the knee joint Hyaluronic acid is distributed throughout the body in epithelial, connective tissues, and neural tissues to promote better joint development and lubrication. Osteoarthritis is a type of arthritis that occurs when the flexible tissue at the ends of bones begins to wear down. Moreover, osteoarthritis is the most common form of arthritis in the world. It can be classified into 2 categories such as primary and secondary osteoarthritis.

Osteoarthritis is characterized by loss of function and degeneration of cartilage and tissues that cover the ends of the bones in a joint. There is not a complete cure for osteoarthritis, hyaluronic acid is thought to improve the lubricating properties of the synovial fluid, provide a more comfortable level of activity, improve mobility, and reduce the pain from osteoarthritis of the knee. The increasing prevalence of osteoarthritis is expected to increase the demand for viscosupplementation products, which is expected to drive the viscosupplementation market growth. According to the World Health Organization (WHO), around 9.6% of men and 18.0% of women aged 60 years and above have symptomatic osteoarthritis worldwide. However, the number is expected to increase due to the growing geriatric population and the obesity epidemic.

Moreover, novel biomimetic polymer viscosupplements are rapidly replacing in-development osteoarthritis joint injections, and thus, key players are focused on increasing research and development in biocompatible polymers. These polymers are widely used in the Food and Drug Administration (FDA) approved stents, surgical meshes, and contact lenses, and help prevent degradation associated with hyaluronate. Furthermore, the viscosupplementation market is expected to witness robust growth in 2021 with a somewhat recovery of emerging and developed economies from the global pandemic (COVID-19).

In terms of geography, the market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Osteoarthritis is the most common joint disorder in the United States. The increasing prevalence of lifestyle-induced disorders, increasing demand for non-surgical treatments for osteoarthritis, and technological advances in the development of hyaluronic acid-based therapies are some of the factors expected to foster the viscosupplementation market growth. For instance, in 2019, Anika Therapeutics showcased HYALOFAST, a biodegradable, hyaluronic acid-based scaffold for cartilage repair at the 2019 International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting.

Viscosupplementation Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, and Johnson & Johnson.

Purchase this Report at Discount Of US $2000 Flat OFF –

Reasons to Purchase this Report

• Current and future of global Viscosupplementation Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players

Major Point Answered in Viscosupplementation Market Research Study are:

  • What will be the progress rate of the Viscosupplementation Market for the conjecture period, 2021-2027?
  • What are the prominent factors driving the Viscosupplementation Market across different regions?
  • Who are the major vendors dominating the Viscosupplementation industry and what are their winning strategies?
  • What will be the market scope for the estimated period?
  • What are the major trends shaping the expansion of the industry in the coming years?
  • What are the challenges faced by the Viscosupplementation Market?

Request Here Sample Report @

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 27-Sep-2021